Company Description
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment.
The company was incorporated in 2016 and is headquartered in Menlo Park, California.
| Country | United States |
| Founded | 2016 |
| IPO Date | Nov 6, 2025 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 620 |
| CEO | Oguzhan Atay |
Contact Details
Address: 1035 O’Brien Drive Menlo Park, California 94025 United States | |
| Phone | (650) 460-2551 |
| Website | billiontoone.com |
Stock Details
| Ticker Symbol | BLLN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $60.00 |
| CIK Code | 0002070849 |
| CUSIP Number | 090168105 |
| ISIN Number | US0901681058 |
| Employer ID | 81-1082020 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Oguzhan Atay, PhD | Chief Executive Officer and Chair of the Board |
| David Tsao, PhD | President, Chief Technology Officer and Director |
| Ross Taylor | Chief Financial Officer |
| Shan Riku Sakakibara | Chief Product Officer |
| Thomas Lynch | General Counsel, Chief Compliance Officer and Secretary |
| Nancy Johnson | Senior Vice President of Sales and Commercial Operations |
| John ten Bosch, PhD | Senior Vice President of Laboratory Operations |
| John Lister | Chief Administrative Officer |
| Thomas Bremner | Director |
| Firat Ileri | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 10, 2025 | 8-K | Current Report |
| Nov 6, 2025 | 424B4 | Prospectus |
| Nov 6, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 5, 2025 | CERT | Certification by an exchange approving securities for listing |
| Nov 3, 2025 | 8-A12B | Registration of securities |
| Oct 17, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Oct 7, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Sep 17, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 11, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 20, 2025 | DRS | [Cover] Draft Registration Statement |